Key Findings
The Asia-Pacific precision medicine market is anticipated to grow at a CAGR of 10.59% during the forecast period, 2021-2028. The rising incidence of diseases and the growing population has strengthened sequencing technologies, thereby raising the demand for genome mapping programs.
Market Insights
Japan, Singapore, China, Australia & New Zealand, Thailand, Malaysia, South Korea, India, and Rest of Asia-Pacific, are evaluated for the Asia-Pacific precision medicine market growth assessment. In Japan, precision medicine is set to be the next big revolution in healthcare. It uses data and technology to focus on individual’s specific health needs, thus eliminating the one-treatment-fits-all model. Japan is a potential market with a growing aging population, strong R&D, and highly advanced technology. Therefore, the country is taking positive steps to boost its precision medicine sector. It was the first country to approve Roche/Chugai’s personalized medicine Rozlytrek (entrectinib), in 2019. The government initiatives are also aimed at raising the demand for precision medicine. Moreover, there is a growing demand for oncology-based precision medicine. Such factors are expected to boost the market growth.
Australia has rapidly growing competency in genomics and precision or personalized medicine. As per Research Australia, Opinion Polling 2018, almost 75% of Australians were reported to be willing to use genetic testing to identify the most effective drug to treat their disease. Moreover, in the past decade, few genomic start-ups have popped up, along with not-for-profit organizations. Such factors are set to offer market growth opportunities.
Competitive Insights
Some of the market’s leading companies are Qiagen NV, Pfizer Inc, Novartis AG, F. Hoffmann-La Roche, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments